CAM
ANIK icon

Capstone Asset Management’s Anika Therapeutics ANIK Stock Holding History

Capstone Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,760
Closed -$228K – 1613
2016
Q3 		$228K Sell
4,760
-70
-1% -$3.46K 0.01% 1466
2016
Q2 		$259K Buy
4,830
+150
+3% +$7.07K 0.01% 1375
2016
Q1 		$209K Buy
+4,680
New +$190K 0.01% 1476
2015
Q4 		– Sell
-6,980
Closed -$222K – 1598
2015
Q3 		$222K Buy
6,980
+210
+3% +$7.32K 0.01% 1429
2015
Q2 		$224K Sell
6,770
-3,720
-35% -$133K 0.01% 1463
2015
Q1 		$432K Buy
10,490
+240
+2% +$9.7K 0.01% 1172
2014
Q4 		$418K Sell
10,250
-920
-8% -$36K 0.01% 1155
2014
Q3 		$409K Buy
11,170
+590
+6% +$25.5K 0.01% 1143
2014
Q2 		$490K Buy
10,580
+1,139
+12% +$50.7K 0.02% 1082
2014
Q1 		$388K Buy
9,441
+130
+1% +$4.83K 0.01% 1250
2013
Q4 		$355K Buy
+9,311
New +$287K 0.01% 1392

Other funds holding ANIK

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capstone Asset Management's ANIK Position: Q4 2016 in Review

Capstone Asset Management sold out of Anika Therapeutics (ANIK) in Q4 2016, closing a stake of 4,760 shares — an estimated $228K sold.

Capstone Asset Management first reported a position in ANIK in Q4 2013 and held it in 11 quarters. The position peaked at $490K in Q2 2014. 158 funds tracked by Wall St. Rank hold ANIK as of Q4 2016.

  • Capstone Asset Management reported no remaining Anika Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Capstone Asset Management sold 4,760 Anika Therapeutics shares in Q4 2016, an estimated $228K.
  • Capstone Asset Management first reported a position in Anika Therapeutics in Q4 2013 and held it in 11 quarters.
  • Capstone Asset Management's Anika Therapeutics position peaked at $490K in Q2 2014.
  • 158 funds tracked by Wall St. Rank held Anika Therapeutics as of Q4 2016.

Based on Capstone Asset Management's 13F filing for Q4 2016, filed 17 Jan 2017.